X4 PHARMACEUTICALS, INC Property, Plant and Equipment, Gross
X4 PHARMACEUTICALS, INC (XFOR) had Property, Plant and Equipment, Gross of $1.44 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $1.44M.
- 2026-03-31: Property, Plant and Equipment, Gross $1.44M.
- 2025-12-31: Property, Plant and Equipment, Gross $1.41M.
- 2025-06-30: Property, Plant and Equipment, Gross $1.42M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $1.44M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.44M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $1.41M 10-Q · filed 2026-08-06 | |
| 2025-06-30 | $1.42M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $2.73M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $2.68M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $2.64M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.55M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.41M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $2.36M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $2.36M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.35M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.34M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.33M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $2.30M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.29M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $2.26M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.24M 10-K · filed 2023-03-21 | |
| 2021-09-30 | $2.27M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.25M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $2.17M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.51M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $1.50M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $787.00K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $775.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $667.00K 10-K · filed 2021-03-19 | |
| 2019-09-30 | $680.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $563.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $448.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $417.00K 10-K · filed 2020-03-12 | $2.56M 10-K · filed 2019-03-11 |
| 2018-03-31 | $2.71M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.64M 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |